Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design
Restricted accessResearch articleFirst published online May, 2021
Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design
Due to poor bioavailability and chemical instability, the effectiveness of curcumin is negligible in the treatment of numerous diseases. Solid lipid nanoparticles (SLNs) increase the bioavailability of lipophilic compounds and protect the drug from gastrointestinal degradation. The objective of our study is the utilization of SLNs to improve the pharmacokinetics and pharmacodynamics of curcumin in the management of diabetes mellitus. Central composite design was used to prepare curcumin-loaded SLNs (Cur-SLN). The analysis of independent variables like drug concentration, lipid concentration, and surfactant concentration was carried out using analysis of variance (ANOVA) to obtain the optimized batch (optimized Cur-SLN) having the desired values of dependent variables particle size and entrapment efficiency. In vitro release, differential scanning calorimeter (DSC), transmission electron microscopy (TEM), and Fourier Transform Infra-Red (FTIR) studies of optimized Cur-SLN were carried out and then its pharmacokinetic and pharmacodynamic studies were performed. The model was found to be significant for particle size and entrapment efficiency based on F-value and p-value. The optimized batch's predicted values were in close agreement with the actual values of particle size and entrapment efficiency. TEM results confirm mono-dispersion and spherical shape of particles in the formulation. The DSC results confirmed the changing of drug from crystalline to amorphous form. Burst release followed by the sustained release was obtained in the in vitro release studies. The pharmacokinetic study shows enhanced bioavailability of optimized Cur-SLN compared with a plain drug suspension. The optimized Cur-SLN achieved higher antidiabetic activity in streptozotocin-induced diabetes mellitus rats than the plain drug suspension. SLNs can be used as a promising technique for delivering curcumin in the management of diabetes mellitus.
Get full access to this article
View all access options for this article.
References
1.
WangW, ChenT, XuH, et al.: Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer. Molecules, 2018; 23:1578.
2.
SharmaS, SharmaJB, BhattS, et al.: Method development and validation of UV spectrophotometric method for the quantitative estimation of curcumin in simulated nasal fluid. Drug Res, 2020; 70:356–359.
3.
MinafraL, PorcinoN, BravatàV, et al.: Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Sci Rep, 2019; 9:1–6.
4.
ReddyPH, ManczakM, YinX, et al.: Protective effects of Indian spice curcumin against amyloid-β in Alzheimer's disease. J Alzheimers Dis, 2018; 61:843–866.
5.
El-FarYM, ZakariaMM, GabrMM, et al.: Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation. Nanomedicine (Lond), 2017; 12:1689–1711.
6.
HeX, YangL, WangM, et al.: Targeting the endocannabinoid/CB1 receptor system for treating major depression through antidepressant activities of curcumin and dexanabinol-loaded solid lipid nanoparticles. Cell Physiol Biochem, 2017; 42:2281–2294.
7.
LiJ, AnY, WangJN, et al.: Curcumin targets vascular endothelial growth factor via activating the PI3K/Akt signaling pathway and improves brain hypoxic-ischemic injury in neonatal rats. Korean J Physiol Pharmacol, 2020; 24:423.
8.
Sundar Dhilip KumarS, HoureldNN, AbrahamseH: Therapeutic potential and recent advances of curcumin in the treatment of aging-associated diseases. Molecules, 2018; 23:835.
9.
ZhangDW, FuM, GaoSH, et al.: Curcumin and diabetes: a systematic review. Evid Based Complementary Altern Med, 2013; 2013:636053.
10.
NeeratiP, DevdeR, GangiAK: Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother Res, 2014; 28:1796–1800.
11.
TangJ, JiH, RenJ, et al.: Solid lipid nanoparticles with TPGS and Brij 78: a co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro. Oncol Lett, 2017; 13:389–395.
12.
SharmaJB, BhattS, SharmaA, et al.: Recent advances in curcumin nanocarriers for the treatment of different types of cancer with special emphasis on in vitro cytotoxicity and cellular uptake studies. Nanosci Nanotechnol Asia, 2020; 10:577–590.
13.
RanaSS, BhattS, KumarM, et al.: Design and optimization of itraconazole loaded SLN for intranasal administration using central composite design. Nanosci Nanotechnol Asia, 2020; 10:884–891.
14.
GanesanP, RamalingamP, KarthivashanG, et al.: Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. Int J Nanomed, 2018; 13:1569.
15.
ChirioD, PeiraE, DianzaniC, et al.: Development of solid lipid nanoparticles by cold dilution of microemulsions: curcumin loading, preliminary in vitro studies, and biodistribution. Nanomaterials, 2019; 9:230.
16.
BhattS, SharmaJ, SinghM, et al.: Solid lipid nanoparticles: a promising technology for delivery of poorly water-soluble drugs. Acta Pharm Sci, 2018; 56:27–49.
17.
HeXL, YangL, WangZJ, et al.: Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder. Neural Regen Res, 2021; 16:537.
18.
GanesanP, KimB, RamalingamP, et al.: Antineuroinflammatory activities and neurotoxicological assessment of curcumin loaded solid lipid nanoparticles on LPS-stimulated BV-2 microglia cell models. Molecules, 2019; 24:1170.
19.
GonçalezML, RigonRB, Pereira-da-SilvaMA, et al.: Curcumin-loaded cationic solid lipid nanoparticles as a potential platform for the treatment of skin disorders. Pharmazie Int J Pharm Sci, 2017; 72:721–727.
20.
PivariF, MingioneA, BrasacchioC, et al.: Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients, 2019; 11:1837.
21.
SunJ, BiC, ChanHM, et al.: Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B Biointerfaces, 2013; 111:367–375.
22.
GaurPK, MishraS, BajpaiM, et al.: Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. Biomed Res Int, 2014; 2014:363404.
23.
SznitowskaM, WolskaE, BaranskaH, et al.: The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN). Eur J Pharm Biopharm, 2017; 110:24–30.
24.
DasS, NgWK, TanRB: Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. Eur J Pharm Sci, 2012; 47:139–151.
25.
DoktorovovaS, SoutoEB, SilvaAM: Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Pharm Dev Technol, 2018; 23:96–105.
26.
ShahB, KhuntD, BhattH, et al.: Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci, 2015; 78:54–66.
27.
HazzahHA, FaridRM, NasraMM, et al.: Gelucire-based nanoparticles for curcumin targeting to oral mucosa: preparation, characterization, and antimicrobial activity assessment. J Pharm Sci, 2015; 104:3913–3924.
28.
ÖztürkAA, YenilmezE, ArslanR, et al.: Dexketoprofen trometamol loaded solid lipid nanoparticles (SLNs): formulation, in vitro and in vivo evaluation. J Res Pharm, 2020; 24:82–99.
29.
BehbahaniES, GhaediM, AbbaspourM, et al.: Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: application of central composite design, thermal analysis and X-ray diffraction techniques. Ultrason Sonochem, 2017; 38:271–280.
30.
BanC, JoM, ParkYH, et al.: Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Food Chem, 2020; 302:125328.
31.
DudhipalaN, JangaKY: Lipid nanoparticles of zaleplon for improved oral delivery by Box–Behnken design: optimization, in vitro and in vivo evaluation. Drug Dev Ind Pharm, 2017; 43:1205–1214.
32.
BagdeA, PatelK, KutlehriaS, et al.: Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength. Drug Deliv Transl Res, 2019; 9:816–827.
33.
PadhyeSG, NagarsenkerMS: Simvastatin solid lipid nanoparticles for oral delivery: formulation development and in vivo evaluation. Indian J Pharm Sci, 2013; 75:591.
34.
PriyankaK, SahuPL, SinghS: Optimization of processing parameters for the development of Ficus religiosa L. extract loaded solid lipid nanoparticles using central composite design and evaluation of antidiabetic efficacy. J Drug Deliv Sci Technol, 2018; 43:94–102.
35.
RahmanMA, HarwanshRK, IqbalZ: Systematic development of sertraline loaded solid lipid nanoparticle (SLN) by emulsification-ultrasonication method and pharmacokinetic study in sprague-dawley rats. Pharm Nanotechnol, 2019; 7:162–176.
36.
Wójcik-PastuszkaD, KrzakJ, MacikowskiB, et al.: Evaluation of the release kinetics of a pharmacologically active substance from model intra-articular implants replacing the cruciate ligaments of the knee. Materials, 2019; 12:1202.
37.
DashS, MurthyPN, NathL, et al.: Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm, 2010; 67:217–223.
38.
BruschiML: Strategies to modify the drug release from pharmaceutical systems. In: Mathematical and Physicochemical Models of Drug Release, 2nd ed. Woodhead Publishing, Cambridge, UK, 2015.
39.
ChenK, ChenX, HanX, et al.: A comparison study on the release kinetics and mechanism of bovine serum albumin and nanoencapsulated albumin from hydrogel networks. Int J Biol Macromol, 2020; 163:1291–1300.
40.
ZhangQ, PolyakovNE, ChistyachenkoYS, et al.: Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. Drug Deliv, 2018; 25:198–209.
41.
ShuklaM, JaiswalS, SharmaA, et al.: A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev Ind Pharm, 2017; 43:847–861.
42.
LiJ, JiangY, WenJ, et al.: A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome. Biomed Chromatogr, 2009; 23:1201–1207.
43.
PrisillaDH, BalamuruganR, ShahHR: Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats. Asian Pac J Trop Biomed, 2012; 2:S941–S946.
44.
AnchiP, KhuranaA, SwainD, et al.: Dramatic improvement in pharmacokinetic and pharmacodynamic effects of sustain release curcumin microparticles demonstrated in experimental type 1 diabetes model. Eur J Pharm Sci, 2019; 130:200–214.
45.
AgarwalS, MurthyRS, HarikumarSL, et al.: Quality by design approach for development and characterisation of solid lipid nanoparticles of quetiapine fumarate. Curr Comput Aided Drug Des, 2020; 16:73–91.
46.
ShahM, PathakK: Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2 3 full-factorial design. AAPS PharmSciTech, 2010; 11:489–496.
47.
KhamesA, KhaleelMA, El-BadawyMF, et al.: Natamycin solid lipid nanoparticles–sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Int J Nanomed, 2019; 14:2515.
48.
TianH, LuZ, LiD, et al.: Preparation and characterization of citral-loaded solid lipid nanoparticles. Food Chem, 2018; 248:78–85.
49.
AndradeLN, OliveiraDM, ChaudMV, et al.: Praziquantel-solid lipid nanoparticles produced by supercritical carbon dioxide extraction: physicochemical characterization, release profile, and cytotoxicity. Molecules, 2019; 24:3881.
50.
BhattH, RompicharlaSV, KomanduriN, et al.: Development of curcumin-loaded solid lipid nanoparticles utilizing glyceryl monostearate as single lipid using QbD approach: characterization and evaluation of anticancer activity against human breast cancer cell line. Curr Drug Deliv, 2018; 15:1271–1283.
51.
SiepmannJ, PeppasNA: Higuchi equation: derivation, applications, use and misuse. Int J Pharm, 2011; 418:6–12. Wadetwar RN, Agrawal AR, Kanojiya PS. In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: in-vitro and ex-vivo evaluation. J Drug Deliv Sci Technol 2020; 418:101575.
52.
WadetwarRN, AgrawalAR, KanojiyaPS: In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: in-vitro and ex-vivo evaluation. J Drug Deliv Sci Technol, 2020; 56:101575.
